BR:NYSEBroadridge Financial Solutions, Inc. Analysis
Data as of 2026-05-20 - not real-time
$149.43
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Broadridge (BR) is trading at $149.43, notably below its DCF‑derived fair value of $158.25 and the analyst consensus target around $207, implying a material upside. Technical indicators show the price sitting just under the 20‑day SMA (152.48) and well below the 50‑day SMA (160.66), while the 200‑day SMA remains far higher at 209.19, confirming a short‑term bearish bias. However, the MACD line has crossed above its signal line, delivering a bullish histogram, and the RSI sits at 42, suggesting room for further gains without immediate overbought pressure. Volume trends are increasing, and the stock’s beta of 0.16 indicates low market‑wide volatility, though the 30‑day realized volatility is elevated at 31%, reflecting recent price swings. On the fundamentals side, BR delivers a robust ROE of 42%, solid revenue growth of 7.8%, and a healthy free cash flow generation exceeding $1.1 bn, supporting its 2.59% dividend yield with a modest 40% payout ratio. The recent $500 million senior notes issuance to refinance higher‑cost debt and the announced strategic partnership and tokenization expansion signal continued investment in growth initiatives. Taken together, the valuation gap, resilient cash generation, and dividend sustainability position BR as an attractive entry point for investors seeking both growth and income.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near short‑term support and below key moving averages
- Bullish MACD crossover despite overall bearish trend
- Increasing volume indicating renewed buying interest
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Valuation upside to DCF fair value and analyst targets
- Strong cash flow and low payout ratio supporting dividend growth
- Strategic initiatives (senior notes refinancing, tokenization partnership) driving earnings expansion
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- High ROE and consistent revenue growth underpinning durable profitability
- Sustainable dividend yield with ample free cash flow
- Positioning in fintech infrastructure with long‑term secular demand
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin15.03%
P/E Ratio16.0
ROE42.31%
ROA9.17%
Debt/Equity120.88
P/B Ratio6.1
Op. Cash Flow$1.4B
Free Cash Flow$1.2B
Industry P/E38.0
Technical Analysis
TrendBearish
RSI41.9
Support$139.79
Resistance$162.94
MA 20$152.48
MA 50$160.66
MA 200$209.19
MACDBullish
VolumeIncreasing
Fear & Greed Index89.18
Valuation
Fair Value$158.25
Target Price$206.50
Upside/Downside38.19%
GradeUndervalued
TypeGrowth
Dividend Yield2.59%
Risk Assessment
Beta0.16
Volatility31.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.